Niloofar Rahmani

Array ( [id] => 5875416 [patent_doc_number] => 20060167039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Nicotinic alpha-7 receptor ligands and preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/312831 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17263 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167039.pdf [firstpage_image] =>[orig_patent_app_number] => 11312831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4576116 [patent_doc_number] => 07855296 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-12-21 [patent_title] => 'Method for synthesizing 2-carbomethoxytropinone' [patent_app_type] => utility [patent_app_number] => 11/303309 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5761 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855296.pdf [firstpage_image] =>[orig_patent_app_number] => 11303309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 42907 [patent_doc_number] => 07781456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Enantiomers of 3-heteroaryl-8H-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 11/793137 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7167 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781456.pdf [firstpage_image] =>[orig_patent_app_number] => 11793137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632376 [patent_doc_number] => 20060148846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Crystalline forms of a factor Xa inhibitor' [patent_app_type] => utility [patent_app_number] => 11/302692 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 14572 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148846.pdf [firstpage_image] =>[orig_patent_app_number] => 11302692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458722 [patent_doc_number] => 20090258874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'PYRAZOLO-HETEROARYL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/721822 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16124 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258874.pdf [firstpage_image] =>[orig_patent_app_number] => 11721822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629433 [patent_doc_number] => 08008320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => '3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors' [patent_app_type] => utility [patent_app_number] => 11/721292 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6168 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008320.pdf [firstpage_image] =>[orig_patent_app_number] => 11721292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5490906 [patent_doc_number] => 20090291977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'Chromane Derivatives Useful As Acid Pump Antagonists' [patent_app_type] => utility [patent_app_number] => 11/721453 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291977.pdf [firstpage_image] =>[orig_patent_app_number] => 11721453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596924 [patent_doc_number] => 20060160842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Heteroaryl fused aminoalkyl imidazole derivates: selective modulators of GABAA receptors' [patent_app_type] => utility [patent_app_number] => 11/295173 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24035 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160842.pdf [firstpage_image] =>[orig_patent_app_number] => 11295173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285501 [patent_doc_number] => 20090099176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDES' [patent_app_type] => utility [patent_app_number] => 11/792185 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25766 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099176.pdf [firstpage_image] =>[orig_patent_app_number] => 11792185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4540228 [patent_doc_number] => 07875627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-25 [patent_title] => 'Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/293012 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16046 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/875/07875627.pdf [firstpage_image] =>[orig_patent_app_number] => 11293012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189664 [patent_doc_number] => 08183377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Process for the preparation of imidazopyridines' [patent_app_type] => utility [patent_app_number] => 11/990880 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1871 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183377.pdf [firstpage_image] =>[orig_patent_app_number] => 11990880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 880136 [patent_doc_number] => 07354922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Bridged ring NK1 antagonists' [patent_app_type] => utility [patent_app_number] => 11/291363 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33338 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354922.pdf [firstpage_image] =>[orig_patent_app_number] => 11291363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614448 [patent_doc_number] => 20060116376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Therapeutic pyrazolo[3,4-B]pyridines and indazoles' [patent_app_type] => utility [patent_app_number] => 11/287759 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36220 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116376.pdf [firstpage_image] =>[orig_patent_app_number] => 11287759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596922 [patent_doc_number] => 20060160840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Tetrahydroisoquinolines as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/284805 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22730 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160840.pdf [firstpage_image] =>[orig_patent_app_number] => 11284805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558867 [patent_doc_number] => 20090270444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => '1,7-Naphthyridines' [patent_app_type] => utility [patent_app_number] => 11/718892 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6615 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270444.pdf [firstpage_image] =>[orig_patent_app_number] => 11718892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5416933 [patent_doc_number] => 20090042820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Tubulin Binding Anti Cancer Agents And Prodrugs Thereof' [patent_app_type] => utility [patent_app_number] => 11/791420 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 31409 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042820.pdf [firstpage_image] =>[orig_patent_app_number] => 11791420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439813 [patent_doc_number] => 07259265 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Coumarin compounds and method for preparing and using the same' [patent_app_type] => utility [patent_app_number] => 11/273372 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6354 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259265.pdf [firstpage_image] =>[orig_patent_app_number] => 11273372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5727583 [patent_doc_number] => 20060058344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/270303 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10191 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058344.pdf [firstpage_image] =>[orig_patent_app_number] => 11270303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844603 [patent_doc_number] => 20060122238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Hydroxybenzoate salts of metanicotine compounds' [patent_app_type] => utility [patent_app_number] => 11/270753 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15571 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122238.pdf [firstpage_image] =>[orig_patent_app_number] => 11270753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5844602 [patent_doc_number] => 20060122237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Hydroxybenzoate salts of metanicotine compounds' [patent_app_type] => utility [patent_app_number] => 11/270018 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15561 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20060122237.pdf [firstpage_image] =>[orig_patent_app_number] => 11270018 [rel_patent_id] =>[rel_patent_doc_number] =>)